| Target- | 
| MechanismCholesterol absorption inhibitors | 
|  | 
|  | 
|  | 
| Inactive Indication- | 
| Drug Highest PhaseApproved | 
| First Approval Ctry. / Loc.Germany | 
| First Approval Date20 Jun 1999 | 
100 Clinical Results associated with HOYER GmbH
0  Patents (Medical) associated with HOYER GmbH
100 Deals associated with HOYER GmbH
100 Translational Medicine associated with HOYER GmbH